IQOS USA

IQOS USA: FAQs

In this article, we answer the most frequently asked questions (FAQs) about the IQOS Launch in the USA. What is IQOS? IQOS is a tobacco

Read More »

IQOS USA: FDA Review

October 2023 Projecting a faster path to the break-even in the USA with IQOS ILUMA, Philip Morris International (PMI) will refrain from investing heavily on

Read More »

IQOS USA: History

Philip Morris International (PMI) & Altria: On the way to Merger In 2013, Altria and PMI entered into a series of agreements related to innovative

Read More »

IQOS USA: Patent Wars

Mart 2024 The US International Trade Commission (ITC) decided to lift the IQOS importation ban following the global patent infringement settlement between British American Tobacco

Read More »

IQOS USA: Product Portfolio

Until IQOS ILUMA receives authorization (marketing order) from the US FDA (not expected before July 2025), Philip Morris International (PMI) will introduce the IQOS3 line-up

Read More »

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address